SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
SHAC was delisted on the 9th of December, 2022.
0 hedge funds and large institutions have $0 invested in SCP & CO Healthcare Acquisition Company Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 67 closing their positions.
100% less funds holding
Funds holding: 68 → 0 (-68)
100% less capital invested
Capital invested by funds: $212M → $0 (-$212M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 67
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$17.1M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$17.1M |
| 3 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$11M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$10.9M |
| 5 |
Millennium Management
New York
|
-$10.8M |
SHAC Hedge Fund Activity: Q4 2022 in Review
0 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) for Q4 2022, worth a combined $0 — down 100% from $212M a quarter earlier.
Sellers outnumbered buyers: 67 funds closed out of SHAC and 0 opened new positions — a net loss of 67 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Balyasny Asset Management, exiting entirely with an estimated $17.1M sold.
- 0 institutional investors held SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) as of Q4 2022, down from 68 in Q3 2022.
- Funds reported $0 of SCP & CO Healthcare Acquisition Company Class A Common Stock stock for Q4 2022, down 100% quarter-over-quarter.
- 0 funds opened new SCP & CO Healthcare Acquisition Company Class A Common Stock positions in Q4 2022 and 67 closed out, a net change of -67 holders.
- The largest SCP & CO Healthcare Acquisition Company Class A Common Stock seller in Q4 2022 was Balyasny Asset Management, an estimated $17.1M sold.
Based on aggregated 13F filings for Q4 2022.